We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Differentiating Septic Arthritis from Lyme Disease Arthritis in Children’s Knees

By LabMedica International staff writers
Posted on 24 May 2016
The two conditions often include similar symptoms and both can show elevated measurements in laboratory tests for inflammation and for white blood cell (WBC) counts – however each condition requires different immediate treatment. More...
A new study identifies symptoms that are predictive of septic arthritis when the condition presents itself in a child’s knee – an important distinction in areas where Lyme disease is endemic.

Septic arthritis is considered a medical emergency and includes the need for surgical irrigation (flushing) and drainage to prevent rapid and irreversible destruction of the cartilage surrounding the knee. Lyme disease is treated with antibiotics. In addition to knee swelling and pain, both conditions may cause a fever, swelling of other joints, irritability, and an inability to bear weight on the affected extremity.

Researchers at Children’s Hospital of Philadelphia (CHOP; Philadelphia, PA, USA) performed a retrospective review study of records of 189 patients under age 18 who presented with excess fluid in the knee between 2005 and 2013. Patients with either septic arthritis (positive joint-fluid culture or synovial WBC count of >60,000 WBC/mm3 with negative Lyme titer) or Lyme disease (positive Lyme immunoglobulin G on Western blot analysis) were included. Of the 189 patients: 23 had culture-positive septic arthritis; 26 had culture-negative septic arthritis; and 140 had Lyme disease.

Upon statistical analysis, 4 characteristics were identified as independent predictive factors for pediatric septic arthritis: presence of knee pain with short range of motion, C-reactive protein of >4.0 mg/liter (CRP test used to measure inflammation), patient-reported history of fever, and age younger than 2 years. The more factors that are present, the higher the risk of having septic arthritis.

“The probability of septic arthritis with any 1 factor present was 18% compared to 100% with all 4 factors present," said study author Wudbhav N. Sankar, MD, orthopaedic surgeon at CHOP, "Our study offers a useful prediction algorithm to help distinguish septic arthritis from a knee effusion caused by Lyme disease in children.”

The study, by Baldwin KD et al, was published May 4, 2016, in the Journal of Bone and Joint Surgery.

Related Links:
Children’s Hospital of Philadelphia


New
Gold Member
Latex Test
SLE-Latex Test
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Staining System
RAL DIFF-QUIK
New
Silver Member
Quality Control Material
Multichem ID-B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: Brain biomarkers of Alzheimer\'s disease can be detected as early as middle age (Photo courtesy of University of Shutterstock)

Blood-Based Biomarkers Could Detect Alzheimer's as Early as Middle Age

As the global population ages, Alzheimer's disease and other dementing diseases are becoming more prevalent. The disease processes leading to Alzheimer's symptoms can begin years or even decades before... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: Micrograph showing the distribution of misfolded proteins in myeloma cells (Photo courtesy of Helmholtz Munich)

Novel Method Tracks Cancer Treatment in Cells Without Dyes or Labels

Multiple myeloma is a blood cancer that affects plasma cells in the bone marrow, leading to abnormal protein production, weakened immunity, and organ damage. Traditional methods for evaluating myeloma... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.